Table 1.
Baseline characteristics according to initial KRT modality
| TW-HD (N = 166) | I-HD (N = 68) | PD (N = 79) | P-value | |
|---|---|---|---|---|
| Age (years) | 62.8 ± 15.7 | 59.7 ± 16.9 | 62.5 ± 16.8 | 0.422 |
| Gender (men) | 113 (68.0%) | 46 (67.6%) | 54 (68.3%) | 0.996 |
| Smoker | 45 (27.6%) | 22 (35.4%) | 16 (20.7%) | 0.155 |
| Diabetes | 84 (50.6%) | 21 (30.8%) | 28 (35.4%) | 0.007 |
| HT | 145 (87.3%) | 52 (76.4%) | 66 (83.5%) | 0.118 |
| CV disease | 74 (44.5% | 27 (39.7%) | 31 (39.2%) | 0.656 |
| ESKD causeDM and/or HTGlomerulonephritisOther |
88 (53.3%) 18 (10.9%) 59 (35.7%) |
27 (39.7%) 16 (23.5%) 25 (36.7%) |
42 (53.1%) 17 (21.5%) 20 (25.3%) |
0.034 |
| Cardiorenal syndrome | 5 (3.0%) | 3 (4.4%) | 9 (11.3%) | 0.024 |
| Charlson score | 7.3 ± 3.0 | 6.3 ± 2.6 | 6.8 ± 3.0 | 0.047 |
| AVF | 26 (15.6%) | 25 (36.7%) | NA | <0.001 |
| Urgent KRT initiation | 56 (33.7%) | 28 (41.1%) | 9 (11.3%) | <0.001 |
| Late referral | 57 (34.3%) | 26 (38.2%) | 12 (15.1%) | 0.003 |
| Sodium (mmol/l) | 137.4 ± 4.7 | 138.4 ± 3.7 | 137.2 ± 5.3 | 0.226 |
| Potassium (mmol/l) | 4.5 ± 0.8 | 4.6 ± 0.9 | 4.4 ± 0.7 | 0.318 |
| Bicarbonate (mmol/l) | 20.4 ± 4.3 | 20.6 ± 5.3 | 22.5 ± 4.4 | 0.007 |
| PTH (pmol/l) | 37.4 ± 40.2 | 38.1 ± 27.5 | 37.4 ± 28.5 | 0.992 |
| Calcium (mmol/l) | 2.21 ± 0.26 | 2.12 ± 0.22 | 2.29 ± 0.21 | <0.001 |
| Phosphate (mmol/l) | 2.08 ± 0.66 | 2.09 ± 0.58 | 1.85 ± 0.56 | 0.024 |
| Albumin (g/l) | 30.9 ± 6.1 | 35.8 ± 6.7 | 34.8 ± 6.1 | <0.001 |
| eGFR at KRT initiation (mL/min/1.73 m2) | 7.7 ± 3.5 | 6.6 ± 3.0 | 8.3 ± 4.7 | 0.021 |
| KRU (mL/min) | 2.2 ± 1.9a | 3.1 ± 2.1 | 4.1 ± 2.3 | <0.001 |
| Urine output at KRT initiation (mL) | 1220 ± 717a | 1851 ± 759 | 1732 ± 691 | <0.001 |
aAvailable in a subgroup of 75 patients only.
Abbreviations: CV, cardiovascular; DM, diabetes; HT, hypertension; PTH, parathormone. Bold values indicate P <0.05.